Amniotic stem cells

Swedish-American Life Science Summit, SALSS 2021, takes place in Stockholm, Sweden, on October 20 to 22 - an exciting return to a physical summit with topnotch International Covid-19 experts and leaders within Cell & Gene therapy!

Retrieved on: 
Tuesday, October 19, 2021
Mobius, Linda, Dan Patch Rising Star Award, Program, Summit, Politics, List of life sciences, Technology, Cell, State, State epidemiologist (Sweden), Singularity University, Moderna, MIT, Koch Institute, Access International Advisors, Amniotic stem cells, Vaccine, Private equity, Therapy, Company, Stockholm City Hall, Industry, Pandemic, Rising Star, Communication, Speaker, Rising Star Award, COVID-19, Science, Pharmaceutical industry

It has made Stockholm into a deal making hub for Life Science,which makes us very proud,"says Barbro C. Ehnbom, Founder and Chairman of SALSS.

Key Points: 
  • It has made Stockholm into a deal making hub for Life Science,which makes us very proud,"says Barbro C. Ehnbom, Founder and Chairman of SALSS.
  • The focus of SALSS this year is Cell & Gene Therapy and lessons learned from Covid-19 with a wide range of panel discussions and presentations.
  • It will also include Company Presentations, a Rising Star exhibit and announcement of the winner of the SALSS Rising Star Award 2021.
  • For more information on SALSS, visit www.salss.com or please contact:
    Linda kesson, Communications, SALSS, +46 (0)70 916 94 16, [email protected]

FTC Returns Almost $515,000 to Consumers Who Bought Deceptively Marketed “Amniotic Stem Cell Therapy” Between 2014 and 2017

Retrieved on: 
Tuesday, April 30, 2019
Branches of biology, Biology, Medicine, Stem cells, Stem-cell therapy, Amniocentesis, Amniotic stem cells, Cerebral palsy

The Federal Trade Commission is mailing 270 checks totaling nearly $515,000 to consumers who paid for what the agency alleged was deceptively advertised amniotic stem cell therapy between 2014 and 2017.

Key Points: 
  • The Federal Trade Commission is mailing 270 checks totaling nearly $515,000 to consumers who paid for what the agency alleged was deceptively advertised amniotic stem cell therapy between 2014 and 2017.
  • and the companies he owns and operates, Regenerative Medical Group and Telehealth Medical Group, deceptively advertised that their amniotic stem cell therapy could treat serious diseases, including Parkinsons disease, autism, macular degeneration, cerebral palsy, multiple sclerosis, and heart disease.
  • The FTC never requires consumers to pay money or provide account information to cash a refund check.
  • FTC law enforcement actions led to more than $2.3 billion in refunds for consumers in a one-year period between July 2017 and June 2018.

FTC Returns Almost $515,000 to Consumers Who Bought Deceptively Marketed “Amniotic Stem Cell Therapy” Between 2014 and 2017

Retrieved on: 
Tuesday, April 30, 2019
Branches of biology, Biology, Medicine, Stem cells, Stem-cell therapy, Amniocentesis, Amniotic stem cells, Cerebral palsy

The Federal Trade Commission is mailing 270 checks totaling nearly $515,000 to consumers who paid for what the agency alleged was deceptively advertised amniotic stem cell therapy between 2014 and 2017.

Key Points: 
  • The Federal Trade Commission is mailing 270 checks totaling nearly $515,000 to consumers who paid for what the agency alleged was deceptively advertised amniotic stem cell therapy between 2014 and 2017.
  • and the companies he owns and operates, Regenerative Medical Group and Telehealth Medical Group, deceptively advertised that their amniotic stem cell therapy could treat serious diseases, including Parkinsons disease, autism, macular degeneration, cerebral palsy, multiple sclerosis, and heart disease.
  • The FTC never requires consumers to pay money or provide account information to cash a refund check.
  • FTC law enforcement actions led to more than $2.3 billion in refunds for consumers in a one-year period between July 2017 and June 2018.